HILPDA and cancer: Consistent with the ability of ATGL to bind to and inhibit ATGL [19,20], gain and loss of function studies have shown that HILPDA promotes triglyceride accumulation in hepatocytes [[21], [22], [23]], macrophages [[24], [25], [26]], and cancer cells [20,27].